The stock is in a severe and sustained downtrend, with a 1-year price change of -52.12% and a 3-month decline of -47.68%. The current price of $8.23 is trading near the bottom of its 52-week range, at just 39% of the distance from the 52-week low of $7.95 to the high of $21.08, indicating the stock is deeply oversold and pricing in significant distress. Recent momentum remains sharply negative, with the stock down -8.76% over the past month, which aligns with and accelerates the longer-term downtrend, driven by persistent sector fears. The stock's beta of 1.205 indicates it is approximately 20% more volatile than the broader market, which has been evident in its dramatic underperformance relative to the SPY, which is up 29.52% over the past year. Key technical support is at the 52-week low of $7.95, while resistance is far above at the 52-week high of $21.08; a breakdown below $7.95 would signal a complete loss of technical footing, while any meaningful recovery would require a sustained move above recent local highs near $11-12.

Revenue growth has been robust on a year-over-year basis, with Q4 2025 revenue of $755.6 million representing a 19.68% increase from the prior year. However, sequential quarterly revenue has been volatile, declining from $727.99 million in Q3 to $755.6 million in Q4, and the net income margin remains thin at 6.31% for the latest quarter. Profitability is present but inconsistent, with Q4 2025 net income of $47.7 million and a gross margin of 62.0%, yet the trailing twelve-month EPS is a mere $0.0078, reflecting significant quarterly volatility in earnings. The balance sheet shows a high degree of financial leverage with a debt-to-equity ratio of 1.75, which elevates risk in a rising rate environment. Positively, the company generated substantial free cash flow of $1.20 billion on a TTM basis and maintains a current ratio of 0.28, though the low current ratio indicates limited short-term liquidity relative to obligations.